IOP ED denied as duplicate or overlapping therapy by Aetna?

Aetna's specific coverage criteria for iop ed are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna May Deny Intensive Outpatient Program (IOP) for Eating Disorders as "Duplicate Therapy"

A "duplicate therapy" denial for an eating disorder Intensive Outpatient Program (IOP) typically occurs when Aetna determines that another level of care you are currently receiving — most commonly individual outpatient therapy, dietitian visits, or a concurrent partial hospitalization program (PHP) — overlaps with the services provided by the IOP. Aetna treats this as paying twice for functionally equivalent treatment. This denial is common and frequently incorrect, because IOP for eating disorders is a structured, multi-disciplinary level of care that is clinically distinct from individual outpatient sessions.

## Why This Denial Is Appealable

IOP and standard outpatient therapy serve different clinical functions. IOP delivers structured group therapy, medical monitoring, nutritional rehabilitation, and multi-disciplinary coordination at a frequency and intensity that individual outpatient care cannot replicate. The Mental Health Parity and Addiction Equity Act (MHPAEA) also prohibits insurers from applying coverage limitations to mental health and eating disorder treatment that are more restrictive than those applied to analogous medical or surgical benefits — and "duplicate therapy" denials applied selectively to behavioral health services are a recognized MHPAEA compliance issue.

## Federal Appeal Framework

• Internal appeal: File within the deadline shown on your EOB. Request Aetna's written clinical criteria for the duplicate-therapy determination and the specific services they identified as overlapping.
• External review: Under ACA §2719, if the internal appeal fails, you have approximately four months from the final adverse determination to request an IRO review. External reviewers assess whether the duplicate-therapy rationale is clinically supported.
• Expedited review: If your eating disorder presents an imminent health risk (e.g., medical instability, significant malnutrition), request expedited review; decisions are typically required within 72 hours.

## Documentation to Gather

1. Clinical differentiation letter from your treatment team: A letter explaining the specific services and goals of the IOP versus any concurrent outpatient treatment, with clear articulation of why the two levels of care are not duplicative. 2. Treatment plan: The IOP's formal treatment plan showing the structured components (group therapy frequency, medical monitoring, nutritional support, psychiatric oversight) that distinguish it from individual outpatient care. 3. Diagnosis and severity documentation: Current chart notes establishing your eating disorder diagnosis, clinical severity, and why step-down to outpatient-only care is not yet clinically appropriate. 4. MHPAEA argument: If applicable, a written argument that Aetna's duplicate-therapy rationale is applied more restrictively to eating disorder treatment than to analogous medical conditions.

## Criteria-Mapping Structure

Obtain Aetna's published clinical policy for IOP and for the level of care they claim is duplicative. For each stated overlap, provide a point-by-point clinical rebuttal documenting the distinct service components, frequency, and clinical goals of the IOP that are not provided by the other treatment.